ABSTRACT: Cardiac troponin, a heterotrimeric protein complex that regulates heart contraction, represents an attractive target for the development of drugs for treating heart disease. Cardiovascular diseases are one of the chief causes of morbidity and mortality worldwide. In France, however, the death rate from heart disease is remarkably low relative to fat consumption. This so-called "French paradox" has been attributed to the high level of consumption of wine in France, and the antioxidant trans-resveratrol is thought to be the primary basis for wine's cardioprotective nature. It has been demonstrated that trans-resveratrol increases the myofilament Ca 2þ sensitivity of guinea pig myocytes [Liew, R., Stagg, M. A., MacLeod, K. T., and Collins, P. (2005) Eur. J. Pharmacol. 519, 1-8]; however, the specific mode of its action is unknown. In this study, the structure of trans-resveratrol free and bound to the calcium-binding protein, troponin C, was determined by nuclear magnetic resonance spectroscopy. The results indicate that trans-resveratrol undergoes a minor conformational change upon binding to the hydrophobic pocket of the C-domain of troponin C. The location occupied by trans-resveratrol coincides with the binding site of troponin I, troponin C's natural binding partner. This has been seen for other troponin C-targeting inotropes and implicates the modulation of the troponin C-troponin I interaction as a possible mechanism of action for trans-resveratrol.
The physiological function of the heart is to pump blood throughout the body to fulfill the oxygen and nutrient demands of the organism. The thin filament in heart muscle is made up of actin, tropomyosin, and troponin. Troponin is a heterotrimeric protein complex formed by the Ca 2þ -binding subunit, troponin C (TnC); 1 the inhibitory subunit, troponin I (TnI); and the tropomyosin-binding subunit, troponin T (TnT). Cardiac TnC (cTnC) has four EF-hand metal-binding sites (I-IV), two in each of its terminal domains. The C-terminal (cCTnC) and N-terminal (cNTnC) domains are connected by a flexible linker, as shown by the NMR (1) and X-ray structures (2) . In cNTnC, site I is defunct and site II is a low-affinity Ca 2þ -binding site; on the other hand, both site III and site IV in cCTnC are functional and can bind either Mg 2þ or Ca 2þ
. During the contraction-relaxation cycle, the cytosolic Ca 2þ concentration dramatically oscillates: at high Ca 2þ levels, cNTnC becomes Ca 2þ -saturated, which primes cNTnC for binding with the "switch" region of cTnI (cTnI [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] ) (3, 4) ; at low Ca 2þ concentrations, Ca 2þ dissociates from cNTnC, leading to the release of cTnI [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] . Alternatively, cCTnC remains saturated with either Mg 2þ or Ca 2þ throughout the contraction cycle and is associated with the "anchoring" region of cTnI (cTnI ), an interaction that may play both structural and regulatory roles (5) . Association of cTnI [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] with cNTnC drags the "inhibitory" region of cTnI (cTnI [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] ) off of actin, and tropomyosin changes its orientation on the thin filament; the myosin binding site is exposed on actin, and myosin binding to actin leads to contraction (for reviews, see refs 6 and 7).
The strength of heart muscle contraction is regulated by the amount of Ca 2þ released from the sarcoplasmic reticulum into the cytosol and by the response of the myofilaments to Ca 2þ . Many popular cardiotonic agents (such as digitalis or dobutamine) improve contraction in the failing heart by elevating the intracellular Ca 2þ concentration; however, intracellular Ca 2þ concentration modulation carries risks associated with Ca 2þ overload such as cardiac arrhythmias, cell injury, or cell death. These limitations have shifted interest to a novel class of cardiotonic drugs, Ca 2þ sensitizers. Ca 2þ sensitizers induce a positive inotropic effect by modulating the myofilament's response to cytosolic Ca 2þ and consequently may circumvent the risks associated with altering Ca 2þ homeostasis (8) . The essential role that cTnC plays in regulation of contraction makes it a logical target for the development of Ca 2þ sensitizers. Several ligands that have been found to have a Ca 2þ sensitizing ability through direct interaction with cTnC include trifluoperazine (TFP) (9) , bepridil (9, 10), levosimendan (11) (12) (13) , and EMD 57033 (14) (15) (16) . While the majority of these compounds target cNTnC to elicit their Ca 2þ sensitizing effects, EMD 57033 functions by targeting cCTnC (15) . In addition, the natural tea polyphenol, epigallocatechin gallate (EGCg), modulates heart muscle contractility through an interaction with cCTnC (17) (18) (19) . These results suggest that both domains of cTnC represent targets for the development of Ca 2þ sensitizers for treating heart failure.
Cardiovascular diseases are the main cause of death worldwide. Interestingly, the mortality rate from heart disease is significantly lower in France than in other countries with comparable diets rich in fat and other risk factors. It has been suggested that this so-called "French paradox" may be attributable to high levels of wine consumption in France (20) . trans-Resveratrol (3, 4 0 ,5-trihydroxystilbene) is produced in grapevines after fungal infection and exposure to ultraviolet light (21) , and Siemann and Creasy proposed that it might be the biologically active ingredient of red wine (22) . trans-Resveratrol (resveratrol) has a variety of reported physiological effects, including antiplatelet aggregation, anti-inflammatory, and antioxidant activity linked to longevity (23, 24) ; protective effects in skin photosensitivity (25) ; neurodegenerative diseases (26) ; cancer chemoprevention (27, 28) ; and cardioprotection (29) . Among its cardioprotective effects, resveratrol has been shown to improve the recovery of ventricular function, including developed pressure in the face of ischemia reperfusion injury (30) . Resveratrol was shown to directly affect the contractile function of guinea pig myocytes, and it increased the level of cell shortening in half the cells tested and decreased the level of shortening in the other half. In the cells where it induced contraction, its relation with the Ca 2þ transients was quantitatively determined, indicating an increase in myofilament Ca 2þ sensitivity (31) . These findings indicate a direct relation between resveratrol and the Ca 2þ -regulated elements in myocytes; however, structural details of this interaction remain unclear.
This study investigates the interaction between cTnC and resveratrol using the structural technique NMR spectroscopy. There have been a number of research groups that describe the applications of relatively sparse NMR data for the determination of the structures of protein-ligand complexes (32) (33) (34) (35) . Recently, Hoffman and Sykes described a procedure for determining the structure of W7 bound with cNTnC using a previously determined structure of cNTnC as a template (36) . A similar protocol was followed here, and it was discovered that resveratrol binds to cCTnC in a manner similar to that of EGCg (19) and EMD 57033 (14) . Several key hydrophobic interactions between cCTnC and resveratrol stabilize the binary structure. It also appears that resveratrol undergoes an only slight conformational change upon binding cCTnC. The solution structure provides clues about the cardioprotective mechanism of resveratrol, and molecular details of the interface between resveratrol and cCTnC may aid in the design of novel cCTnC-targeting drugs.
EXPERIMENTAL PROCEDURES
Sample Preparation. 15 N]cTnC were obtained from Escherichia coli strains containing the expression vector as previously described (37, 38) . trans-Resveratrol was purchased from Sigma-Aldrich Inc. (99% pure as determined by gas chromatography). All NMR samples had volumes of 500 μL and consisted of 100 mM KCl, 10 mM imidazole or 8 mM imidazole-d 4 and 2 mM imidazole, and 0.5 mM DSS-d 6 as an NMR reference standard. Protein concentrations were ∼0.2 mM for full-length cTnC and ∼0.5 mM for cCTnC with 20 and 10 mM CaCl 2 , respectively. The sample pH was maintained at ∼6.9 for all NMR experiments. Although resveratrol naturally exists in cis and trans isomeric forms, transresveratrol was used in this study because of its higher concentrations in red wine (0-15 μg/mL) in contrast with that of cisresveratrol (0-5 μg/mL) (24) . Stock solutions of 20 mM transresveratrol (resveratrol) in a 100 mM tris(2-carboxyethyl)phosphine (TCEP)/DMSO-d 6 solution were prepared. TCEP was used to allay oxidation of resveratrol, which was done for EGCg and ascorbic acid (19, 39) . The resveratrol:cCTnC concentration ratio was ∼4:1 for NMR experiments with the complex. All the stock solutions were prepared fresh prior to each experiment and were wrapped with aluminum foil to prevent photodegradation.
NMR Spectroscopy and Data Processing. The NMR data used for this study were collected on Varian Inova 500 MHz and Unity 600 MHz spectrometers at 30°C or a Varian Inova 800 MHz spectrometer at 25°C. All spectrometers have tripleresonance probes with Z-pulsed field gradients. One-dimensional ) was used for the analysis of one-dimensional NMR spectra, and all two-dimensional and three-dimensional NMR data were processed with NMRPipe (45) and analyzed with NMRView (46) . Chemical shifts of cCTnC were assigned using those deposited for cTnC (1) , and the methionine methyls were assigned from assignments previously determined by mutagenesis (47) . The interaction between resveratrol and cCTnC is in fast exchange, so the resonances from cCTnC could be followed throughout the titration of resveratrol and the assignments translated to the chemical shifts of the cCTnC 3 resveratrol complex.
Resveratrol Assignment and Assessment of Stability. The proton chemical shifts of resveratrol were assigned in D 2 O by the use of one-dimensional H ROESY NMR experiments. To test the stability of resveratrol in aqueous solution, 500 μL samples of ∼0.3 mM resveratrol were prepared in D 2 O. 1 H NMR spectra were recorded in 1 h increments to test for oxidative degradation. Another sample of resveratrol was prepared with 10 mM TCEP, and the sample stability was reassessed. In both samples, the pD was ∼7.0.
NMR Structure and Ab Initio Calculations of Resveratrol Free in Solution. The PRODRG web server (48) was used to create initial coordinates of resveratrol, and XPLO-2D (49) was used to generate topology and parameter files for resveratrol.
The structure of resveratrol was determined by ROE intensities of resveratrol with a mixing time of 200 ms. XPLOR-NIH (50) was used to calculate the solution structure of resveratrol. Four NOEs contributed to the structure calculation, which were binned from strong (2.00-1.80 Å ) to medium (2.80-1.80 Å ) to weak (3.60-1.80 Å ). The simulated annealing comprised square-well potentials for interproton distances and a patch to keep the aromatic rings and olefin bond planar; the aromatic rings of resveratrol were allowed to freely rotate around the C1 0 -CR 0 and C1-CR bonds. One hundred structures were calculated, and the 10 lowest-energy structures were kept. The lowest-energy solution structure of free resveratrol was used as an input structure in Gaussian03 (51) to calculate the total density and electrostatic potential (ESP). The energy calculation was performed in aqueous solvent with Becke's three-parameter Lee N-labeled cCTnC. At each titration point, the HSQC spectra were recorded, and residue specific chemical shift perturbations (CSPs) that were well resolved and underwent a large change were kept for the dissociation constant calculation. Chemical shift changes (Δδ) were calculated using the following equation:
The dissociation constants (K D ) for resveratrol were calculated by using a global fitting approach with xcrvfit (www.bionmr.ualberta. ca/bds/software/xcrvfit), as described previously (52) . Briefly, the set of kept titration curves was fit using a fixed K D range and a floating final shift value (because residues were perturbed to a varying extent). The sum of squared error (SSE) was minimized by optimizing the K D , and thus, a global K D that best fit all the CSPs was calculated. The binding of resveratrol to cTnC and cCTnC was fit with a 1:1 stoichiometry:
Concentrations of cTnC and cCTnC were calculated by integration of the one-dimensional slice of the 1 H- 15 N HSQC spectrum and comparison of the spectral intensity with that of a sample with a protein concentration determined by amino acid analysis. The concentrations of the resveratrol stock solutions were determined via comparison of the proton spectral intensity of resveratrol peaks with the DSS proton intensity. Concentrations of cTnC, cCTnC, and resveratrol were then corrected for dilution that occurred during the titrations. Because the addition of resveratrol slowly decreased the pH of the sample, the pH was adjusted to ∼6.9 with 1 M NaOH when necessary.
j-Surface Mapping. Jsurf was used to localize the binding site of resveratrol on cCTnC. Jsurf approximates the origin of the CSP as a single-point dipole in the center of an aromatic ring from a ligand (53) . With the coordinates of cTnC as input, Jsurf depicts the coordinates of a ligand ring as a dot based on the magnitude and sign of the CSPs. The region that shows the highest dot density is termed the j-surface and is the place where the aromatic constituents of a ligand are most likely to reside. The chemical shifts in the 1 H- 13 C HSQC spectrum of the final point in the titration of cCTnC (CS PL ) with resveratrol were subtracted from the initial chemical shifts of cCTnC (CS P ).
CSP ¼ CS PL -CS P Only peaks that were well-resolved and underwent a concentration-dependent CSP of g0.012 ppm in the proton dimension were used in the analysis; results were displayed with PyMOL.
Calculation of the Structure of the cCTnC 3 Resveratrol Complex. The structure of the cCTnC 3 resveratrol complex was calculated using restraints for cCTnC from the cCTnC 3 EGCg complex because the CSPs induced by both ligands are quite similar. A similar datum-driven protocol has been used for the cNTnC 3 W7 complex (36) . Distance restraints for cCTnC were calibrated with CYANA (54) using an upper limit of 6 Å . Dihedral angle restraints from TALOS (55) were used as well as 12 distance restraints from X-ray crystallographic data of chelating oxygen atoms to the two Ca 2þ ions. CYANA was used to calculate 100 structures of cCTnC, of which the 30 conformers with the lowest target function were used to further refine the structure with XPLOR-NIH. The restraints were converted from CYANA format into XPLOR-NIH format. The simulated annealing protocol of XPLOR-NIH, with 10000 high-temperature steps and 6000 cooling steps, was used in the structure calculation. The NOEs were averaged using the R-6 with a soft well potential. Spin diffusion was a concern because the mixing times of 200 and 250 ms for the measurement of intermolecular NOEs were high. Therefore, only NOEs that had an NOE intensity of gμ -1 / 2 σ were kept for the structure calculation, and all were calibrated with the same distance. A total of 23 intermolecular NOEs (6.0-1.8 Å ) and four intramolecular NOEs (2.6-1.8 Å ) were used in the structure calculation; 100 structures were calculated, from which the 50 lowest-energy structures were kept for refinement in explicit solvent with a water box edge length of 18.8 Å . It has been shown that refinement in explicit solvent including electrostatic potentials can improve the quality of structures (56) . Atomic charges calculated by Gaussian03 for resveratrol (see above) were included at this point in the structure calculation. The final ensemble is represented by the 20 lowest-energy structures after water refinement and was validated by Procheck (57) available with the online Protein Structure Validation Software (PSVS) suite (http://psvs-1_4-dev.nesg.org/), and the structural statistics are listed in Table 1 (62) .
The stability of resveratrol has been addressed previously (63) . The authors found that under acidic conditions, resveratrol was stable for at least 42 h, while at pH 10, resveratrol had a half-life of 1.6 h. Because three-dimensional NMR experiments require a stable sample for 2-3 days and the samples are at neutral pH, the necessity of a reducing agent was investigated. The degradation of resveratrol was measured by acquiring one-dimensional 1 H NMR spectra at 1 h time points. Significant degradation of resveratrol was observed, primarily in the di-m-hydroxyl (di-m-OH) ring (Figure 1b) , and a half-life of 5-6 h was estimated by monitoring the chemical shift change of the H2 and H6 proton pair ( Figure 1 of the Supporting Information). The sample also changed color from clear to brown over the course of 24 h. Next, 10 mM TCEP was added to a sample of resveratrol, and no significant degradation occurred after 1 day (Figure 1c ). There was some decrease in peak intensities; however, there was no change in chemical shift or sample color, even after 72 h.
Structure of Resveratrol in D 2 O. To determine the structure of resveratrol in solution, two-dimensional ROESY spectra were recorded with different mixing times (50, 150, 200 , and 300 ms); the ROE buildup curve is shown in Figure 2 Figure 2b . The CR 0 -CR-C1-C6 and CR-CR 0 -C1 0 -C6 0 torsion angles can be used to describe the orientations of the two phenolic rings with respect to the olefin. In Table 2 , the torsion angles for a number of structures of resveratrol are listed. The p-OH ring is coplanar (0.5 ( 0.3°) with the olefin, whereas the di-m-OH ring is tilted by 43.9 ( 0.4°. The structure of free resveratrol has also been determined by NMR spectroscopy in DMSO (60) and by X-ray crystallography (64); both structures revealed an overall planar structure. The X-ray structure of a trimethoxy derivative of resveratrol was less planar, particularly with respect to the orientation of the di-m-O-CH 3 ring (65). In the crystal structure of resveratrol, extensive hydrogen bonds contribute to the planarity of resveratrol, while the inability of 3,4 0 ,5-trimethoxystilbene to form intermolecular hydrogen bonds resulted in a slight twist of the rings. It is possible that the presence of TCEP in the sample decreased the amount of intermolecular hydrogen bonding of resveratrol by perturbing stacking interactions and may explain the somewhat tilted conformation of the di-m-OH ring. The lowest-energy structure in the ensemble of resveratrol was used to calculate its electronic properties with the quantum chemistry program Gaussian03 (51) (Figure 2c) .
Resveratrol Binding to cTnC. To characterize resveratrol's interaction with troponin, we titrated resveratrol into a sample containing 15 N-labeled cTnC. In addition, the residues that typically experience large perturbations upon binding of cTnI or a ligand to the N-domain (4, 52) such as Gly34, Gly42, Glu66, and Asp73 remained relatively unperturbed. The linear nature of the CSPs is indicative of a 1:1 stoichiometry for resveratrol binding to cTnC. Multiple binding would lead to nonlinear CSPs, which was observed for TFP and bepridil binding to cTnC (9) . Using xcrvfit, the CSPs of the backbone amides of Thr124, Gly125, Ile128, Thr129, Gly140, Gly159, and Glu161 were plotted as a function of resveratrol:cTnC concentration; a global dissociation constant (K D ) of 243 μM (SSE = 0.02) was determined ( Figure 3b of the Supporting Information).
Resveratrol Binding to cCTnC. To test whether the interaction between resveratrol and cTnC was the same as in the isolated C-domain, resveratrol was titrated into cCTnC. Twodimensional N HSQC experiments were used to monitor the titration of resveratrol into a sample containing cCTnC (Figure 3a,b) . The 1 H- 13 C HSQC spectrum (without resveratrol) was assigned using chemical shift assignments deposited for cTnC (1) . Because resveratrol interacts with cCTnC in fast exchange, most assigned resonances could be easily followed throughout the titration. Global dissociation constants of 240 μM (SSE = 0.08) from the backbone amides and 301 μM (SSE = 0.02) from the methyl groups of cCTnC were calculated ( Figure 3) . The residue specific CSPs are almost identical in both pattern and amplitude between the titrations of resveratrol with cCTnC and cTnC ( Figure 3c of the Supporting Information). The comparable dissociation constants and CSP patterns suggest that resveratrol interacts with cCTnC the same as it does with full-length cTnC.
Following determination of the affinity and stoichiometry of the binding of resveratrol to cCTnC, j-surface mapping was conducted to predict resveratrol's binding location on cCTnC. j-Surface mapping works to predict a binding site by assuming that the ring current from an aromatic constituent of a ligand is the primary source of ligand-induced CSPs (53) . Typically, amide protons are used in the calculation; however, it is well-established that cTnC undergoes a large conformational change upon ligand binding. Thus, most of the backbone CSPs are indicative of a global change in its structure rather than direct contact with a given ligand (66) . To circumvent this difficulty, the CSPs of methyl protons were used in the j-surface calculation, as changes in these chemical shifts are more likely indicative of direct interactions with resveratrol. Methyl resonances used in the calculation were those that underwent a g|0.012| ppm change in the proton dimension. These included Ile112, Met120, Leu121, Ala123, Ile128, Ile148, Met157, and Val160. The structure of cTnC (PDB entry 1aj4) (1) was used in the j-surface calculation, and the results localize Ring twist illustrates the orientation of the ring with comparison to the central olefin of resveratrol. The p-OH ring twist is the CR-CR 0 -C1 0 -C6 0 torsion angle; the di-m-OH ring twist is the CR 0 -CR-C1-C6 torsion angle. For the NMR structures, both positive and negative torsions were measured so they are reported in absolute degrees. Multiple values are given when more than one resveratrol is present in the X-ray structures. the binding of resveratrol to the cleft formed by the four helices of cCTnC ( Figure 4 ). There appear to be two j-surfaces: one near the surface of cCTnC and the other deeper in the core. Because the j-surface calculation is unable to identify the specific pose resveratrol adopts when bound to cCTnC, NMR spectroscopy was used to identify intermolecular contacts between resveratrol and cCTnC.
Structure of the cCTnC 3 Resveratrol Complex. The structure of cCTnC free or in complex with a number of binding partners has been determined by both X-ray crystallography and NMR spectroscopy (1, 2, 14, 19, (67) (68) (69) . Instead of determining the structure of cCTnC again, we pursued a datum-driven docking approach. The Figure 4 of the Supporting Information). The CSPs are most similar between resveratrol and EGCg (in both magnitude and pattern); hence, the intramolecular NOEs and dihedral restraints of cCTnC used in the structure calculation were taken from the cCTnC 3 EGCg complex (19) . The only new restraints used in the structure calculation were those that defined the structure and pose of resveratrol in complex with cCTnC.
Intermolecular NOEs were measured between cCTnC and resveratrol with Because most of the intermolecular contacts observed were between methyl groups from cCTnC and the aromatic ring protons of resveratrol, the three-dimensional 13 C-edited/filtered HMQC NOESY experiment (43, 44) was conducted. This NMR experiment is optimized for the identification of intermolecular NOEs involving 13 C-labeled methyls (44) . Two three-dimensional 13 C-edited/ filtered HMQC NOESY experiments were conducted: one with a mixing time of 250 ms and one with a mixing time of 200 ms. Intermolecular NOEs that had intensities of g0.04 were included in the structure calculation. This is because of the long experimental mixing times of the intermolecular NOESY experiments, and the tightly coupled nature of resveratrol increased the likelihood of spin diffusion. When all NOEs were included in the structure run, many violations occurred, presumably because of spin diffusion. The intermolecular NOEs from a mixing time of 200 ms used in the structure calculation are shown in Figure 5a . Initially, a structure calculation followed, similar to what was done for the EGCg calculation. The quality of the structure was subsequently improved by conducting a structure refinement in water; at this stage, electrostatic potentials and atomic charges were included (56) . The 20 lowest-energy structures of the complex are shown in panels b and c of Figure 5 . The structure indicates that, congruent with the prediction by j-surface mapping, resveratrol is localized to the hydrophobic pocket of cCTnC. The resveratrol--cCTnC interaction site is populated primarily by nonpolar contacts. Resveratrol contacts the side chains of Leu100, Leu117, Leu121, Thr124, Leu136, Met157, and Val160 (Figure 5d ). Weak NOEs between resveratrol and Ile148 and Ile112 (both β-sheet residues), not used in the structure run because they did not meet the intensity cutoff criteria, were also consistent with the final structure. In addition to the methyl-resveratrol contacts, the structure indicates that arene-arene contacts formed between resveratrol and Phe104, Phe153, and Phe156 contribute to the binding energy of resveratrol.
In addition to measuring intermolecular NOEs between resveratrol and cCTnC to determine their relative positions, we also determined the conformation of bound resveratrol. The intramolecular NOEs of resveratrol were measured with the N-labeled molecule and keeping only signals from an unlabeled molecule. All structure-defining intramolecular NOEs were close to the same intensity, with the strongest being the H2/H6-HR 0 contact (see Table 1 and Figure  5 of the Supporting Information). This is in contrast with the case for free resveratrol, in which the strongest ROE was between H2 0 / H6 0 and HR, and suggests that resveratrol undergoes a slight conformational change upon binding cCTnC. To limit bias in the structure of resveratrol during the calculation, one distance (2.6-1.8 Å ) for the four intramolecular contacts was used, and the final structure was checked against the raw NOE data. Indeed, the results are consistent with the relative NOE intensities: the closest proton pair was the H2/H6-HR 0 proton pair (2.24 ( 0.14 Å ). The other distances are as follows: H2/H6-HR, 2.57 ( 0.05 Å ; H2 0 /H6 0 -HR 0 , 2.28 ( 0.06 Å ; and H2 0 /H6 0 -HR, 2.32 ( 0.07 Å . The torsion angles were measured for resveratrol in complex with cCTnC and were compared to those determined for free resveratrol. The p-OH ring is more twisted (18.6 ( 10.6°) than in free resveratrol (from 0.5 ( 0.3°), whereas the torsion angle of the di-m-OH ring is not significantly different (43.9 ( 0. 4°vs 35.2 ( 8.7°) .
There have been a number of crystal structures of resveratrol in complex with proteins determined, including alfalfa chalcone synthase (CHS) (70), the fibril-forming transthyretin (TTR) (71), a variant of alfalfa CHS (72), quinone reductase 2 (QR2) (73) , peanut stilbene synthase (STS) (74) , bovine F1-ATPase (75), leukotriene A4 hydrolase (76) , and human cytosolic sulfotransferase (not published; but deposited as PDB entry 3ckl). In most of these structures, resveratrol is planar or slightly distorted from a planar conformation with torsion angles of e45°; the only exception is in the peanut STS 3 resveratrol complex, in which ions are represented by black spheres, and the j-surface dot density is depicted using yellow spheres. Residues used in the j-surface calculation were Leu121, Val160, Ala123, Ile148, Ile128, Met157, Met120, and Ile112.
both rings of resveratrol are twisted >60°(74) (see Table 2 ). These results, in conjunction with the structures of free resveratrol and resveratrol derivatives, point to a relatively rigid resveratrol framework. In accordance with the X-ray and NMR structures, Caruso et al. calculated single-point energy versus the torsion angle of the p-OH ring and found the lowest-energy structure is a planar conformation (64) .
The structure of cCTnC in the cCTnC 3 resveratrol complex is not much different from that of cCTnC in other complexes. The CR atoms from residues in secondary structure elements of the cCTnC 3 resveratrol complex were superimposed with those of cCTnC (PDB entry 3ctn), the cCTnC 3 EMD 57033 complex (PDB entry 1ih0), the cCTnC 3 EGCg complex (PDB entry 2kdh), and the cCTnC 3 cTnI 34-71 complex (PDB entry 1j2d), and rootmean-square deviations of 1.17, 1.50, 1.02, and 1.26 Å , respectively, were determined. These values indicate that resveratrol does not significantly perturb the structure of cCTnC. Helix E of the cCTnC 3 resveratrol complex is shifted away from the hydrophobic cleft, like that of the cCTnC 3 EMD5033 complex. The position of helix F of the cCTnC 3 resveratrol complex is in a position almost identical to that in the cCTnC 3 EGCg and cCTnC 3 cTnI 34-71 complexes; however, it is shifted farther from helix E of cCTnC and not as far as in the cCTnC 3 EMD 57033 complex. 
DISCUSSION
The regulatory role of the Ca 2þ -dependent interaction between cTnI 147-163 and cNTnC is well-established and has been the primary interaction site on which the development of Ca 2þ sensitizers focused (77, 78) . However, the exclusive development of drugs that target cNTnC has been scrutinized as a growing body of evidence indicates that cCTnC is also involved in contraction regulation. The dilated cardiomyopathy mutation of cCTnC, Gly159Asp, decreases myofilament Ca 2þ sensitivity (79) via its modulation of the cTnI 34-71 -cCTnC interaction (67) . The hypertrophic cardiomyopathy mutation, Asp145Glu, increases Ca 2þ sensitivity (80) , presumably by weakening the binding of Ca 2þ and cTnI to cCTnC (81) . The ablation of the Ca 2þ binding ability of the C-domain of cTnC increases the Ca 2þ sensitivity of muscle contraction (82) . There are two isoforms of TnC in insect flight muscle: the F1 isoform that regulates stretch-activated force and the F2 isoform that is responsible for Ca 2þ -activated contraction. Although it is not clear how F1 regulates stretch activation, the interaction between the C-domain of F1 and TnH (an ortholog of cTnI) may play a role (83) . Finally, as previously mentioned, the cardiotonic agents EMD 57033 (15, 84) and EGCg (17, 18) target cCTnC to modulate heart muscle contractility.
In this study, resveratrol was found to interact with the C-domain of cTnC, and the structure was determined by NMR spectroscopy. The p-OH group of resveratrol lies in the hydrophobic core of cCTnC, whereas the di-m-OH ring points toward the exterior of the protein. The stabilizing contacts between resveratrol and cCTnC are predominantly hydrophobic. In the other resveratrol 3 protein complexes, the binding site of resveratrol is also dominated by hydrophobic interactions; however, unlike the structure of the cCTnC 3 resveratrol complex, hydrogen bonds between the hydroxyls of resveratrol and the amino acids that line the binding pockets also contribute to the binding energy (70) (71) (72) (73) (74) (75) (76) . The design of resveratrol with the p-OH group converted to a hydrophobic constituent may therefore increase its affinity for cCTnC; for example, converting the hydroxyl to a fluorine atom would increase the lipophilicity of resveratrol without dramatically decreasing its size (85, 86) . On the other hand, removing the p-OH group would undoubtedly weaken the antioxidant ability of resveratrol, especially given the fact that the p-OH group has been implicated as being the principal hydroxyl responsible for resveratrol's antioxidant nature (64, (87) (88) (89) .
The comparison of the structure of the cCTnC 3 resveratrol complex with the structures of the cCTnC 3 EMD 57033 and cCTnC 3 EGCg complexes yields insights into several key functional groups. In the structure, the p-OH aromatic ring of resveratrol is positioned in a manner similar to that of the thiadiazinone ring of EMD 57033, with the p-hydroxyl pointed toward the cleft formed by helices G and H. The di-m-OH ring of resveratrol faces away from the hydrophobic cavity of cCTnC, much like the benzenediol of EGCg, which leaves its hydroxyl moieties free to form hydrogen bonds with the surrounding aqueous milieu. Therefore, the binding pose of resveratrol has features that uniquely resemble the structures of EGCg and EMD 57033 when bound to cCTnC. Resveratrol, EMD 57033, and EGCg all share their binding sites with the natural binding partner of cCTnC, cTnI ( Figure 6 ), and as a result may have a common mode of action. The troponin-dependent Ca 2þ sensitizing ability of EMD 57033 has been suggested to involve a competition between EMD 57033 and cTnI for cCTnC (90) . The perturbation of the cTnI 34-71 -cCTnC interaction may lead to an increase in the affinity of cTnI 128-147 for cTnC and thus a decrease in the level of inhibition of contraction.
It was determined that resveratrol bound to cTnC and cCTnC with micromolar affinity. This relatively low affinity of resveratrol for cTnC was anticipated, because an overly high affinity would lead to a marked increase in Ca 2þ sensitivity. This dramatic increase in Ca 2þ sensitivity over the long term could lead to negative effects, such as hypertrophic cardiomyopathy. On the other hand, it may be useful to optimize the resveratrol-cCTnC interaction for the development of drugs for treating acute heart failure. One method for the analysis of whether a small molecule represents a good lead molecule is to determine its ligand efficiency (LE) (91) (92) (93) . LE is described by the ratio of the free energy of binding to the number of heavy atoms in a compound and is based on the premise that as a drug is optimized, it often increases in molecular weight, a trend fraught with problems, including a decrease in bioavailability through insolubility and membrane permeability (94) .
The free energy (ΔG) of binding is The reasonably good ligand efficiency of resveratrol suggests that the substitution or addition of a few atoms that enhance its affinity for cCTnC may lead to novel therapies for the treatment of heart failure.
CONCLUSION
Resveratrol is a natural product found in wine that modulates the Ca 2þ sensitivity of myofilaments (31) . In this study, the structure of resveratrol in complex with the cardiac regulatory protein troponin C was determined by NMR spectroscopy. Consistent with the small molecules EGCg and EMD 57033, resveratrol targeted the C-domain of troponin C. The binding of resveratrol is primarily stabilized by hydrophobic contacts such as methylarene and arene-arene interactions. In addition to providing clues about the cardioprotective nature of resveratrol, the structure highlights several functional groups that could be modified to optimize the binding efficacy of resveratrol. Recently, the polyphenol, propyl gallate, has also been identified to act as a Ca 2þ sensitizer (95) , which alongside the functional and structural data for EGCg and resveratrol, points to a common mechanism by which these natural compounds target the thin filament to protect against heart failure.
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